Alliance of India’s 26 top drugmakers opposes generic drug substitution at Janaushadhi Kendras

Alliance of India’s 26 top drugmakers opposes generic drug substitution at Janaushadhi Kendras

New Delhi: A group of top Indian pharma companies has reached out to the central government opposing a proposal to allow government-run Janaushadhi Kendras to dispense substitutes of prescription medications, including anti-cancer, antibiotics, and habit-forming drugs, ThePrint has learnt. At present, India has over 10,600 Janaushadhi Kendras or stores — a network of generic drug … Read more

Pharma exports grew 10% to $28 billion in FY24, poised to hit $31 billion in FY25: Pharmexcil

Pharma exports grew 10% to  billion in FY24, poised to hit  billion in FY25: Pharmexcil

India’s pharma industry is poised to grow to around $130 billion by 2030 (Representative Image/ Reuters) HYDERABAD: India’s pharmaceutical exports clocked a nearly 10% growth in FY24 to hit $27.8 billion, propelled by the double digit growth in the US and UK generics market, and is poised to reach $31 billion in the current fiscal … Read more

Tirzepatide, another diabetes drug cleared for weight loss in US, yet to get regulator nod in India

Tirzepatide, another diabetes drug cleared for weight loss in US, yet to get regulator nod in India

New Delhi On 8 November, the US Food and Drug Administration (FDA) approved the use of tirzepatide by US pharma company Eli Lilly exclusively for obesity management. The injectable tirzepatide is indicated for type 2 diabetes with the additional benefit of causing weight loss, and has been a global smash hit since its launch in … Read more